Note: Ingredients listed on restricted chemical lists
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
1310-73-2
Name of the chemical
Potassium or sodium hydroxide (20)
Concentration
N/A
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
General Information
Revision date
2018-09-07
Product name
Micafungin Sodium for Injection, 50 mg/vial and 100 mg/vial
Chemical name
Micafungin Sodium for Injection
REACH No
medicinal
1.2.1 Relevant identified uses
Pharmaceutical product Antifungal
Emergency telephone
800 424 9300
Icons in SDS
Company Information
company name
Xellia Pharmaceuticals ApS
e-mail address of the competent person responsible for the Safety Data Sheet
sales@xellia.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H400
Hazard statements
Code
Statements
H400
Very toxic to aquatic life
Section 2
SECTION 2: Hazards identification
Emergency Overview This is a medicinal product that may affect body functions. When inside vials the hazard is considered negligible. Physical Appearance: Pharmaceutical white powder in vials Hazards (if the vial is broken): Adverse developmental effects in rats and rabbits.
2.1 Classification of the substance or mixture
CLP: GHS09 (Environment); Aquatic Acute 1;H400 (Very toxic to aquatic life). HAZARD SIGN:
Contains
Micafungin Sodium WARNING H400: Very toxic to aquatic life. P273: Avoid release to the environment.
2.3 Other hazards
None known. PBT/vPvB: The substance is not considered PBT/vPvB according to criteria in Annex XIII.